Opportunity ID: 354573

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-24-216
Funding Opportunity Title: Minor Use Minor Species Development of Drugs (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Agriculture
Consumer Protection
Food and Nutrition
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: May 29, 2024
Last Updated Date: May 29, 2024
Original Closing Date for Applications: Jan 29, 2027 Application Due Dates are as follows: July 29, 2024; January 31, 2025; July 25, 2025; January 30, 2026; July 24, 2026; January 29, 2027
Current Closing Date for Applications: Jan 29, 2027 Application Due Dates are as follows: July 29, 2024; January 31, 2025; July 25, 2025; January 30, 2026; July 24, 2026; January 29, 2027
Archive Date: Feb 28, 2027
Estimated Total Program Funding: $250,000
Award Ceiling: $250,000
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Native American tribal governments (Federally recognized)
County governments
For profit organizations other than small businesses
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Independent school districts
State governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: • Faith-based or Community-based Organizations• Regional Organizations• Non-domestic (non-U.S.) Entities (Foreign Organizations)

Additional Information

Agency Name: Food and Drug Administration
Description:

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). 

The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.

Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.

The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species “designation” granted by FDA/CVM’s Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.

FDA/CVM’s Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

Link to Additional Information: PAR-24-216 Funding Opportunity Announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Terrin Brown

Grantor
Email:terrin.brown@fda.hhs.gov

Version History

Version Modification Description Updated Date
Close date updated. May 29, 2024
Clarification on close date has been added. May 29, 2024
Link Description has been added. May 29, 2024

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-24-216
Funding Opportunity Title: Minor Use Minor Species Development of Drugs (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Agriculture
Consumer Protection
Food and Nutrition
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: May 29, 2024
Last Updated Date: May 29, 2024
Original Closing Date for Applications: Jan 29, 2027 Application Due Dates are as follows: July 29, 2024; January 31, 2025; July 25, 2025; January 30, 2026; July 24, 2026; January 29, 2027
Current Closing Date for Applications: Jan 29, 2027 Application Due Dates are as follows: July 29, 2024; January 31, 2025; July 25, 2025; January 30, 2026; July 24, 2026; January 29, 2027
Archive Date: Feb 28, 2027
Estimated Total Program Funding: $250,000
Award Ceiling: $250,000
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Native American tribal governments (Federally recognized)
County governments
For profit organizations other than small businesses
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Independent school districts
State governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: • Faith-based or Community-based Organizations• Regional Organizations• Non-domestic (non-U.S.) Entities (Foreign Organizations)

Additional Information

Agency Name: Food and Drug Administration
Description:

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). 

The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.

Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.

The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species “designation” granted by FDA/CVM’s Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.

FDA/CVM’s Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

Link to Additional Information: PAR-24-216 Funding Opportunity Announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Terrin Brown

Grantor
Email:terrin.brown@fda.hhs.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-24-216
Funding Opportunity Title: Minor Use Minor Species Development of Drugs (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Agriculture
Consumer Protection
Food and Nutrition
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 29, 2024
Last Updated Date: May 29, 2024
Original Closing Date for Applications:
Current Closing Date for Applications: – Application Due Dates are as follows: July 29, 2024; January 31, 2025; July 25, 2025; January 30, 2026; July 24, 2026; January 29, 2027
Archive Date: Feb 28, 2027
Estimated Total Program Funding: $250,000
Award Ceiling: $250,000
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Small businesses
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
State governments
Additional Information on Eligibility: • Faith-based or Community-based Organizations• Regional Organizations• Non-domestic (non-U.S.) Entities (Foreign Organizations)

Additional Information

Agency Name: Food and Drug Administration
Description:

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). 

The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.

Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.

The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species “designation” granted by FDA/CVM’s Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.

FDA/CVM’s Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

Link to Additional Information: PAR-24-216 Funding Opportunity Announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Terrin Brown

Grantor
Email:terrin.brown@fda.hhs.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-24-216
Funding Opportunity Title: Minor Use Minor Species Development of Drugs (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Agriculture
Consumer Protection
Food and Nutrition
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 29, 2024
Last Updated Date: May 29, 2024
Original Closing Date for Applications:
Current Closing Date for Applications: Jan 29, 2027 Application Due Dates are as follows: July 29, 2024; January 31, 2025; July 25, 2025; January 30, 2026; July 24, 2026; January 29, 2027
Archive Date: Feb 28, 2027
Estimated Total Program Funding: $250,000
Award Ceiling: $250,000
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Small businesses
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
State governments
Additional Information on Eligibility: • Faith-based or Community-based Organizations
• Regional Organizations
• Non-domestic (non-U.S.) Entities (Foreign Organizations)

Additional Information

Agency Name: Food and Drug Administration
Description:

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). 

The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.

Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.

The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species “designation” granted by FDA/CVM’s Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.

FDA/CVM’s Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

Link to Additional Information: PAR-24-216 Funding Opportunity Announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Terrin Brown

Grantor
Email:terrin.brown@fda.hhs.gov

Related Documents

Packages

Agency Contact Information: Terrin Brown
Grantor
Email: terrin.brown@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 PAR-24-216 FORM H PKG00286737 May 29, 2024 Jan 29, 2027 View

Package 1

Mandatory forms

354573 RR_SF424_5_0-5.0.pdf

354573 PHS398_CoverPageSupplement_5_0-5.0.pdf

354573 RR_OtherProjectInfo_1_4-1.4.pdf

354573 PerformanceSite_4_0-4.0.pdf

354573 RR_KeyPersonExpanded_4_0-4.0.pdf

354573 RR_Budget_3_0-3.0.pdf

354573 PHS398_ResearchPlan_5_0-5.0.pdf

354573 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

354573 RR_SubawardBudget30_3_0-3.0.pdf

354573 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T16:11:06-05:00

Share This Post, Choose Your Platform!

About the Author: